Diploide Genetics
Diploide Genetics is a life science and research technologies company providing human genome next-generation sequencing (NGS) solutions to enable precision medicine. They focus on diagnosis and biomarker discovery for chronic/rare diseases and cancer, offering personalized and flexible services. Leveraging advanced NGS platforms and bioinformatics expertise, Diploide Genetics aims to make medical genetics accessible and affordable. The company also utilizes CRISPR-Cas technologies for gene editing in developing next-generation medicines and applies artificial intelligence to synthesize biomedical knowledge for biomarker strategy and patient recruitment. Their laboratories in the US, Canada, Asia, and Europe are CAP and CLIA certified, ensuring high-quality genetic testing. Diploide Genetics collaborates with academic and scientific communities to integrate new technologies, including AI and machine learning, to accelerate the development of novel therapies.
Diploide Genetics
Diploide Genetics is a life science and research technologies company providing human genome next-generation sequencing (NGS) solutions to enable precision medicine. They focus on diagnosis and biomarker discovery for chronic/rare diseases and cancer, offering personalized and flexible services. Leveraging advanced NGS platforms and bioinformatics expertise, Diploide Genetics aims to make medical genetics accessible and affordable. The company also utilizes CRISPR-Cas technologies for gene editing in developing next-generation medicines and applies artificial intelligence to synthesize biomedical knowledge for biomarker strategy and patient recruitment. Their laboratories in the US, Canada, Asia, and Europe are CAP and CLIA certified, ensuring high-quality genetic testing. Diploide Genetics collaborates with academic and scientific communities to integrate new technologies, including AI and machine learning, to accelerate the development of novel therapies.